Compugen (CGEN) Earnings Analysis
Compugen (CGEN) next reports earnings on 2026-08-03, consensus EPS -0.07 USD. Last quarter (2026-05-18) it missed with EPS -0.08 USD vs -0.07 USD est (-14.3%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E 6.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CGEN next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | -0.07 USD |
| Revenue estimate | 0.00B |
CGEN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-18 | -0.08 USD | -0.07 USD | -14.3% | Miss |
| 2026-03-02 | 0.6 USD | -0.07 USD | +957.1% | Beat |
| 2025-11-10 | -0.07 USD | -0.09 USD | +22.2% | Beat |
| 2025-05-19 | -0.08 USD | -0.06 USD | -33.3% | Miss |
| 2025-03-04 | -0.07 USD | 0.07 USD | -200% | Miss |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
CGEN valuation and analyst view
| Trailing P/E | 6.60 |
|---|---|
| Trailing EPS | 0.36862 USD |
| Price / book | 2.40 |
| Dividend yield | 0.00% |
| Market cap | 0.23B |
| Analyst consensus | Buy (13 buy / 0 hold / 1 sell) |
| Avg price target | 5 USD |
Related research pages
Frequently asked questions
When is Compugen (CGEN)'s next earnings date?
Compugen is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.07 USD and revenue estimate of 0.00B.
Did CGEN beat earnings last quarter?
In its 2026-05-18 report, CGEN posted EPS of -0.08 USD versus a -0.07 USD estimate — a miss of 14.3%.
What is CGEN's earnings track record?
Over the last 5 reported quarters with consensus data, CGEN beat estimates 2 times (40%).
What is CGEN's current P/E ratio and EPS?
CGEN trades at a trailing P/E of 6.60 on trailing EPS of 0.3686166421821175 USD.
What do analysts rate CGEN?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 13 buy, 0 hold, 1 sell, 0 strong sell). Average 12-month price target: 5 USD.